Clinical significance of HSP27 expression in colorectal cancer

Molecular Medicine Reports

Volumn 3, Issue 6, 2010, Pages 953-958

  Yu, Zhijin ^a   Zhi, Junli ^b   Peng, Xiaofeng ^a   Zhong, Xuhui ^a   Xu, Angao ^a  

^a HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; HSP27; Prognosis

Indexed keywords

HEAT SHOCK PROTEIN 27;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROTEIN EXPRESSION;

EID: 78649468568     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.372     Document Type: Article

References (40)

1. Moghaddam AA, Woodward M and Huxley R: Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16: 2533-2547, 2007.
2. Inomata M, Yasuda K, Shiraishi N and Kitano S: Clinical evidences of laparoscopic versus open surgery for colorectal cancer. Jpn J Clin Oncol 39: 471-477, 2009.
3. Hundt S, Haug U and Brenner H: Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 16: 1935-1953, 2007.
4. Brundel BJ, Ke L, Dijkhuis AJ, Qi XY, Shiroshita-Takeshita A, Nattel S, Henning RH and Kampinga HH: Heat shock proteins as molecular targets for intervention in atrial fibrillation. Cardiovasc Res 78: 422-428, 2008.
5. Pockley AG: Heat shock proteins, inflammation, and cardiovascular disease. Circulation 105: 1012-1017, 2002.
6. Nollen EA and Morimoto RI: Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. J Cell Sci 115: 2809-2816, 2002.
7. Westerheide SD and Morimoto RI: Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem 280: 33097-33100, 2005.
8. Matsui Y, Hadaschik BA, Fazli L, Andersen RJ, Gleave ME and So AI: Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancer. Mol Cancer Ther 8: 2402-2411, 2009.
9. Tetu B, Brisson J, Landry J and Huot J: Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma: an immunohistochemical study. Breast Cancer Res Treat 36: 93-97, 1995.
10. Geisler JP, Tammela JE, Manahan KJ, Geisler HE, Miller GA, Zhou Z and Wiemann MC: HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up. Eur J Gynaecol Oncol 25: 165-168, 2004.
11. Giaginis C, Daskalopoulou SS, Vgenopoulou S, Sfiniadakis I, Kouraklis G and Theocharis SE: Heat shock protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival. BMC Gastroenterol 9: 14, 2009.
12. Foster CS, Dodson AR, Ambroisine L, Fisher G, Moller H, Clark J, Attard G, De-Bono J, Scardino P, Reuter VE, Cooper CS, Berney DM and Cuzick J: Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J Cancer 101: 1137-1144, 2009.
13. Ioachin E: Immunohistochemical tumour markers in endometrial carcinoma. Eur J Gynaecol Oncol 26: 363-371, 2005.
14. Joo M, Chi JG and Lee H: Expressions of HSP70 and HSP27 in hepatocellular carcinoma. J Korean Med Sci 20: 829-834, 2005.
15. Storm FK, Mahvi DM and Gilchrist KW: Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers. Urology 42: 379-382, 1993.
16. Tavernier E, Duval A, Cornillon J, Flandrin P, Guyotat D and Campos L: Prognostic value of CXCR4, adhesion molecules and heat shock proteins (HSP) in acute myelogenous leukemia. Blood (ASH Annual Meeting Abstracts) 110: 2848, 2007.
17. Ciocca DR and Calderwood SK: Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10: 86-103, 2005.
18. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E and Kroemer G: Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5: 2592-2601, 2006.
19. Liu W, Ma Y, Huang L, Peng J, Zhang P, Zhang H, Chen J and Qin H: Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis. Mol Biol Rep (In press).
20. Schimanski CC, Schwald S, Simiantonaki N, Jayasinghe C, Gönner U, Wilsberg V, Junginger T, Berger MR, Galle PR and Vloehler M: Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 11: 1743-1750, 2005.
21. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, Gurbuxani S, Arrigo AR Kroemer G, Solary E and Garrido C: Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2: 645-652, 2000.
22. Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP and Solary E: HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13: 2061-2070, 1999.
23. Lavoie JN, Gingras-Breton G, Tanguay RM and Landry J: Induction of Chinese hamster HSP27 gene expression in mouse cells confers resistance to heat shock. HSP27 stabilization of the microfilament organization. J Biol Chem 268: 3420-3429, 1993.
24. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J and Landry J: Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 110: 357-368, 1997.
25. Wyttenbach A, Sauvageot O, Carmichael J, Diaz-Latoud C, Arrigo AP and Rubinsztein DC: Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum Mol Genet 11: 1137-1151, 2002.
26. Konishi H, Matsuzaki H, Tanaka M, Takemura Y, Kuroda S, Ono Y and Kikkawa U: Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27. FEBS Lett 410: 493-498, 1997.
27. Charette SJ and Landry J: The interaction of Hsp27 with Daxx identifies a potential regulatory role of Hsp27 in Fas-induced apoptosis. Ann NY Acad Sci 926: 126-131, 2000.
28. Guo K, Kang NX, Li Y, Sun L, Gan L, Cui FJ, Gao MD and Liu KY: Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cell apoptosis. BMC Cancer 9: 100, 2009.
29. Chauhan D, Li G, Shringarpure R, Podar K, Ohtake Y, Hideshima T and Anderson KC: Blockade of Hsp27 overcomes bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells. Cancer Res 63: 6174-6177, 2003.
30. Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK and Fuqua SA: The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res 53: 4443-4448, 1993.
31. Hansen RK, Parra I, Lemieux P, Oesterreich S, Hilsenbeck SG and Fuqua SA: Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat 56: 187-196, 1999.
32. Song TF, Zhang ZF, Liu L, Yang T, Jiang J and Li PL: Small interfering RNA-mediated silencing of heat shock protein 27 (HSP27) increases chemosensitivity to paclitaxel by increasing production of reactive oxygen species in human ovarian cancer cells (HO8910). J Int Med Res 37: 1375-1388, 2009.
33. Teimourian S, Jalal R, Sohrabpour M and Goliaei B: Down-regulation of Hsp27 radiosensitizes human prostate cancer cells. Int J Urol 13: 221-1225, 2006.
34. Aloy MT, Hadchity E, Bionda C, Diaz-Latoud C, Claude L, Rousson R, Arrigo AP and Rodriguez-Lafrasse C: Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells. Int J Radiat Oncol Biol Phys 70: 543-553, 2008.
35. Hadchity E, Aloy MT, Paulin C, Armandy E, Watkin E, Rousson R, Gleave M, Chapet O and Rodriguez-Lafrasse C: Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma. Mol Ther 17: 1387-1394, 2009.
36. Nakajima M, Kuwano H, Miyazaki T, Masuda N and Kato H: Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma. Cancer Lett 178: 99-106, 2002.
37. Garrido C, Fromentin A, Bonnotte B, Favre N, Moutet M, Arrigo AP, Mehlen P and Solary E: Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res 58: 5495-5499, 1998.
38. Choi DH, Ha JS, Lee WH, Song JK, Kim GY, Park JH, Cha HJ, Lee BJ and Park JW: Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells. FEBS Lett 581: 1649-1656, 2007.
39. Tsuruta M, Nishibori H, Hasegawa H, Ishii Y, Endo T, Kubota T, Kitajima M and Kitagawa Y: Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer. Oncol Rep 20: 1165-1172, 2008.
40. Kawanishi K, Shiozaki H, Doki Y, Sakita I, Inoue M, Yano M, Tsujinaka T, Shamma A and Monden M: Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer 85: 1649-1657, 1999.